Clinical Trials Logo

Myalgia clinical trials

View clinical trials related to Myalgia.

Filter by:

NCT ID: NCT06054490 Completed - Clinical trials for Myalgia of Mastication Muscle

Self-management and Home Exercises for the Treatment of Masticatory Muscle Pain. A Clinical Trial

Start date: January 2016
Phase: N/A
Study type: Interventional

The objective of this study was to compare the clinical effectiveness of self-management (SM) together with mandibular home exercises (EX) in the treatment of myalgia of the masticatory muscles. A controlled clinical trial was carried out with a total of 48 subjects diagnosed with myalgia according to the diagnostic criteria for temporomandibular disorders (DC/TMD), who were randomized into two groups: treated with SM (SM group) and treated with SM and mandibular home exercises (SM-EX group). The follow-ups were carried out at 2, 6 and 10 weeks, where the following were evaluated: pain in the masticatory muscles, range of mandibular movement and mandibular functional limitation.

NCT ID: NCT06006481 Completed - Muscle Pain Clinical Trials

Musculoskeletal Problems and Strategies Developed by Physiotherapists to Cope With Them

Start date: September 1, 2023
Phase:
Study type: Observational

The aim of this study is to investigate whether there is a difference in areas such as occupational musculoskeletal injuries and strategies developed by physiotherapists working in different fields, burnout and occupational satisfaction.

NCT ID: NCT06005246 Recruiting - Clinical trials for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)

Munich ME/CFS Cohort Study

MUC-CFS
Start date: January 22, 2019
Phase:
Study type: Observational

The Munich cohort study MUC-CFS aims at the characterization and long-term follow-up of myalgic encephalitis/chronic fatigue syndrome (ME/CFS) in young people aged up to 25 years, as well as at the identification of pathomechanisms, biomarkers, and targets for future treatment approaches.

NCT ID: NCT05998603 Completed - Muscle Soreness Clinical Trials

Pre-sleep Protein Supplementation and Load Carriage Recovery in British Army Recruits

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Load carriage is a common military activity and has been shown to induce acute exercise-induced muscle damage (EIMD) and impair muscle function. Protein supplementation can accelerate muscle recovery by attenuating EIMD and muscle function loss. This study investigated the impact of an additional daily bolus of protein prior to sleep throughout training on acute muscle recovery following a load carriage test in British Army recruits. Muscle function (maximal jump height), perceived muscle soreness and urinary markers of muscle damage were assessed before (PRE), immediately post (POST), 24-hours post (24h-POST) and 40-hours post (40h-POST) a load carriage test.

NCT ID: NCT05982665 Completed - Inflammation Clinical Trials

Effect of Inhaled Molecular Hydrogen on Recovery Process After Downhill Walking on the Treadmill

Start date: August 14, 2023
Phase: N/A
Study type: Interventional

This study assesses the effect of molecular hydrogen inhalation in healthy males on muscle soreness, fatigue, oxidative stress, and inflammation following eccentric muscle contraction during downhill walking on the treadmill.

NCT ID: NCT05961501 Not yet recruiting - Headache Clinical Trials

The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin

Start date: July 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of the study is to evaluate the effectiveness of an aqueous solution containing CBD and CBN in the management of Facial Pain and Headache of Muscular Origin. A randomized (block randomization), double-blind, two-arm controlled trial will involve 42 adult patients diagnosed with Facial Pain and Headache of Muscular Origin which is lasting more than 3 months on the basis of clinical examination. Qualified study participants will be randomly assigned to two groups. The studied group will receive tan aqueous solution containing CBD and CBN, to drink at home in the dose determined by the attending physician, while the control group will receive an aqueous solution of placebo, to drink at home in the dose determined by the attending physician during this time. Each subject will be tested on the qualification day (D0), on 20 days after D0 (D20), and then 40 (D40) and 60 (D60) days after the qualification day using electromyography (EMG), pressure pain threshold test (PPT), clinical examination and surveys.

NCT ID: NCT05929755 Recruiting - Pain, Postoperative Clinical Trials

Depo-Medrol on Psoas After LLIF

Start date: May 12, 2023
Phase: Phase 4
Study type: Interventional

The goal of this study is to determine the effects of a corticosteroid administered to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) on postoperative hip flexor weakness and thigh pain and numbness.

NCT ID: NCT05926752 Recruiting - Pelvic Pain Clinical Trials

Photobiomodulation for Myofascial Pelvic Pain

PMPP
Start date: October 27, 2021
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the efficacy of photobiomodulation of the pelvic floor muscles in female Veterans with chronic pelvic pain. The main questions it aims to answer are: - Is there a difference in reduction in overall pelvic pain between women who undergo photobiomodulation compared to women who received pelvic floor physical therapy? - Is there a difference in compliance with therapy between the two groups? Participants will be randomized to treatment with either 9 treatments of photobiomodulation (two treatments per week) or 8 weeks of pelvic floor physical therapy (one treatment a week). Researchers will compare both groups to see if there is a difference in overall pelvic pain reduction.

NCT ID: NCT05924139 Completed - Body Composition Clinical Trials

Omega-3 Fatty Acid Supplementation to Enhance Performance

FO n-3
Start date: March 6, 2023
Phase: N/A
Study type: Interventional

The goal of this intervention study is to determine if omega-3 fatty acid supplementation as compared to placebo improves performance in track and field athletes. The main questions it aims to answer are: 1. Can performance be improved 2. Can strength be enhanced 3. Will positive body composition changes occur (lean vs fat mass) 4. Will feelings of muscle soreness be diminished Participants will take either omega-3 fatty acid supplements or placebo and continue with their sport specific training regimen. Researchers will compare the supplement group to placebo group to determine if there are any significant differences.

NCT ID: NCT05907850 Recruiting - Muscle Soreness Clinical Trials

Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes

Start date: June 23, 2023
Phase: Early Phase 1
Study type: Interventional

The aim of this project is to investigate the effects of riboflavin, also known as vitamin B2, on preventing delayed onset muscle soreness (DOMS) in ultramarathon athletes through a randomized placebo-controlled study.